DNTH DNTH Stock Jumps 21.5% Despite Wider-Than-Expected Q4 Loss as Pipeline Prospects Fuel Rally 5 hours ago Dianthus Therapeutics posts wider-than-expected Q4 loss of $1.43/share on collapsing revenue, yet shares surge 21.5% on pipeline optimism.